FIELD: chemistry of organosilicon compounds, medicine, pharmacy.
SUBSTANCE: invention relates to novel compounds and their using in therapy. Invention describes compounds of the formula (I): 
wherein alternate values are given in the invention claim. These substances are claimed as compounds possessing antagonistic activity with respect to GnRH, and pharmaceutical composition comprising these compounds.
EFFECT: valuable medicinal properties of compounds and pharmaceutical composition.
28 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SILICON COMPOUNDS AND THEIR USING | 2004 |
|
RU2303595C2 |
| DERIVATIVES OF THIENO[2,3-D]PYRIMIDINE-2,4-(1H,3H)-DIANE, PHARMACEUTICAL COMPOSITION, METHOD FOR ITS PREPARING, METHOD FOR IMMUNOSUPPRESSION AND METHOD FOR TREATMENT OR REDUCING RISK OF RESPIRATORY WAY OBSTRUCTION | 1998 |
|
RU2225410C2 |
| COMPOUNDS SUITABLE FOR THERAPY AGAINST HIV | 2019 |
|
RU2806030C2 |
| DERIVATIVES OF N-(3-AMINOPROPYL)-N-PHENYL-5,6,7,8-TETRAHYDRO- -NAPHTHALENE-2-CARBOXAMIDE, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2138479C1 |
| BENZOCYCLOALKYLAZOLOTHIONE DERIVATIVES | 1995 |
|
RU2145321C1 |
| METHOD OF USING PROTHIOCONAZOLE TO INDUCE IMMUNE SYSTEM RESPONSE | 2014 |
|
RU2662287C2 |
| HETEROCYCLIC INHIBITORS OF Hh-SYGNAL CASCADE, BASED ON THEM MEDICINAL COMPOSITIONS AND METHOD OF TREATING DISEASES INDUCED BY ABBARANT ACTIVITY OF Hh-SIGNAL SYSTEM | 2007 |
|
RU2364597C1 |
| SUBSTITUTED AMINOINDANS AND ANALOGUES THEREOF TO BE USED IN PHARMACEUTICS | 2009 |
|
RU2522586C2 |
| NEW CRYSTALLINE FORM OF 2-{3-[2-(1-{[3,5-BIS(DIFLUOROMETHYL)-1H-PYRAZOL-1-YL]ACETYL}PIPERIDIN-4-YL)-1,3-THIAZOL-4-YL]-4,5-DIHYDRO-1,2-OXAZOL-5-YL}-3-CHLOROPHENYLMETHANE SULPHONATE | 2014 |
|
RU2691948C2 |
| PHARMACEUTICAL COMPOSITION, INCLUDING TRICYCLIC SULFUR-CONTAINING 1,2-DIHYDROQUINOLINE DERIVATIVE FOR INHIBITION OF REPLICATION OF BETA CORONAVIRUSES, INCLUDING SARS-CoV-2, AND METHOD OF ITS USE | 2021 |
|
RU2814434C1 |
